Gene therapy using anti-inflammatory cytokines promising against ms
Jan 30 , 2018

Gene therapy using anti-inflammatory cytokines promising against ms

BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach against multiple sclerosis (MS).

Source: Cell Journal.

Adam Alonzi

Adam Alonzi is a writer, biotechnologist, documentary maker, futurist, inventor, programmer, and author two novels. He is an analyst for the Millennium Project, and Head of Social Media and Content Creation for BioViva Sciences. Listen to his podcasts here. Read his blog here.